<DOC>
	<DOCNO>NCT01740583</DOCNO>
	<brief_summary>The purpose study test safety device performance Mitralign system ( `` MPAS '' ) treat functional mitral valve regurgitation .</brief_summary>
	<brief_title>Mitralign Percutaneous Annuloplasty System Chronic Functional Mitral Valve Regurgitation</brief_title>
	<detailed_description>The ALIGN study single arm , prospective study . The objective study investigate safety performance catheter-based plication device intend reduce circumference dilate mitral valve . The study enroll 50 subject 5 site ( Paraguay , Columbia , Dominican Republic , Brazil , India ) follow 36 month post index procedure . Enrollment define time study device insert body patient follow 30 day , Months 6 , 12 , 24 36 post index procedure .</detailed_description>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>NYHA IIIV Structurally normal mitral valve At least Grade 2 mitral regurgitation Left ventricular ejection fraction le 20 % great 45 % Left ventricular end diastolic diameter le 5.0 cm great 7.5 cm Pregnant lactate female Mitral stenosis Mod/severe aortic stenosis regurgitation Mod/severe tricuspid stenosis regurgitation Endocarditis Previous mitral valve repair MV replacement Bioprosthetic mechanical aortic valve Known unstable angina MI within 30 day prior procedure CVA within past 6 month Known contraindication blood transfusion , contrast dye , DAPT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>mitral valve , regurgitation , annuloplasty</keyword>
</DOC>